Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Cigna Group (CI) Q2 2024 Earnings Call Transcript
Cigna Group (CI) Q2 2024 Earnings Call Transcript

Image source: The Motley Fool.

Cigna Group (NYSE: CI)Q2 2024 Earnings CallAug 01, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Bull Market Buys: 2 Growth Stocks to Own for the Long Run: https://g.foolcdn.com/editorial/images/784953/astonished-shocked-coffee-newspaper.jpg
Bull Market Buys: 2 Growth Stocks to Own for the Long Run

Investors who buy stocks through both bull and bear markets are the ones who tend to benefit more in the long term because they are growing their portfolios consistently. But a bull market does seem

Is The Trade Desk Stock Going to $105? 1 Wall Street Analyst Thinks So: https://g.foolcdn.com/editorial/images/785100/person-seated-at-a-desk-using-a-laptop.jpg
Is The Trade Desk Stock Going to $105? 1 Wall Street Analyst Thinks So

Next-generation digital advertising platform developer The Trade Desk (NASDAQ: TTD) is an out-of-favor stock that should be getting more investor love. That's according to one pundit following the

DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?: https://g.foolcdn.com/editorial/images/785036/diabetes-cgm-man-in-wheelchair.jpg
DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame?

Going into 2024, DexCom's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from

EQS-News: STRATEC REPORTS CHANGES IN FINANCE DIVISION
EQS-News: STRATEC REPORTS CHANGES IN FINANCE DIVISION
EQS-News: STRATEC REPORTS CHANGES IN FINANCE DIVISION
AEVIS VICTORIA SA (AEVS:SW) achieved revenues of more than CHF 450 million in the first half-year 2024
AEVIS VICTORIA SA (AEVS:SW) achieved revenues of more than CHF 450 million in the first half-year 2024
AEVIS VICTORIA SA (AEVS:SW) achieved revenues of more than CHF 450 million in the first half-year 2024
Why Integra Lifesciences Stock Is Sinking Today: https://g.foolcdn.com/editorial/images/785027/surgery.jpg
Why Integra Lifesciences Stock Is Sinking Today

Shares of Integra Lifesciences (NASDAQ: IART) were sinking 15.5% as of 11 a.m. ET on Monday. The decline came after the medical technology company announced its second-quarter results before the

Why Koninklijke Philips Stock Jumped 14% Today: https://g.foolcdn.com/editorial/images/785026/1-arrow-angles-up-on-a-green-stock-chart.jpg
Why Koninklijke Philips Stock Jumped 14% Today

Koninklijke Philips (NYSE: PHG) stock surged 14.5% through 10:05 a.m. ET Monday after the company reported strong earnings this morning.

Analysts had forecast the Dutch medical devices company would

2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000: https://g.foolcdn.com/editorial/images/784337/listening-laptop-podcast-smiling-happy.jpg
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $1,000

Bull markets come and go, and give way to bear markets, and come back again. The stock market has a remarkable habit of steadily rising with the passage of time. For investors who stay invested

2 Magnificent Growth Stocks to Buy Right Now: https://g.foolcdn.com/editorial/images/784339/man-reading-paper-report-statement-and-using-laptop.jpg
2 Magnificent Growth Stocks to Buy Right Now

Not all stocks have responded to the bull market in the some way. While many businesses have followed the broader trend of steadily rising, some stocks are trading down considerably and even coming

Marjorie Taylor Greene Loves Vanguard ETFs; Here Are 4 She Bought in the First Half of 2024: https://g.foolcdn.com/editorial/images/783942/washington-dc-the-pencil-monument-cherry-blossom-1200x800-5b2df79.jpg
Marjorie Taylor Greene Loves Vanguard ETFs; Here Are 4 She Bought in the First Half of 2024

Sure, how politicians vote on legislation and what they say on the campaign trail are the stuff of intense scrutiny. But that's not the only thing people are following with today's pols.

Retail

Centene (CNC) Q2 2024 Earnings Call Transcript
Centene (CNC) Q2 2024 Earnings Call Transcript

Image source: The Motley Fool.

Centene (NYSE: CNC)Q2 2024 Earnings CallJul 26, 2024, 8:30 a.m. ET

Operator

Continue reading

Source Fool.com

Why DexCom Stock Is Crashing Today: https://g.foolcdn.com/editorial/images/784772/dexcom-cgm-devices-and-apps.png
Why DexCom Stock Is Crashing Today

Shares of DexCom (NASDAQ: DXCM) were crashing 39.9% lower as of 10:20 a.m. ET on Friday. The huge sell-off came after the continuous glucose monitoring (CGM) systems maker announced its

DexCom (DXCM) Q2 2024 Earnings Call Transcript
DexCom (DXCM) Q2 2024 Earnings Call Transcript

Image source: The Motley Fool.

DexCom (NASDAQ: DXCM)Q2 2024 Earnings CallJul 25, 2024, 4:30 p.m. ET

Operator

Continue reading

Source Fool.com

Got $5,000? These 3 Growth Stocks Are Incredibly Cheap Buys Right Now: https://g.foolcdn.com/editorial/images/784061/a-couple-of-investors-looking-at-a-series-of-charts.jpg
Got $5,000? These 3 Growth Stocks Are Incredibly Cheap Buys Right Now

Buying quality growth stocks doesn't have to involve paying an enormous premium. There are some solid, underrated companies worth buying right now that don't trade at egregious valuations. While

EQS-News: Drägerwerk AG & Co. KGaA: Dräger on track to meet annual forecast after a solid first half-year
EQS-News: Drägerwerk AG & Co. KGaA: Dräger on track to meet annual forecast after a solid first half-year
EQS-News: Drägerwerk AG & Co. KGaA: Dräger on track to meet annual forecast after a solid first half-year
Humana Healthy Horizons Commits to Increasing Healthcare Access for Oklahomans: https://mms.businesswire.com/media/20240724798615/en/2193938/5/BA_Groundbreaking_-_Brent_-_Humana_Team2.jpg
Humana Healthy Horizons Commits to Increasing Healthcare Access for Oklahomans


Humana Healthy Horizons, the Medicaid business of leading health and well-being company Humana Inc. (NYSE: HUM), is investing in community-based organizations throughout Oklahoma to expand access

This Ultra-High-Yield Dividend Stock Hits Yet Another Setback: https://g.foolcdn.com/editorial/images/784193/a-person-looking-at-a-red-stock-chart-on-a-tablet.jpg
This Ultra-High-Yield Dividend Stock Hits Yet Another Setback

Medical Properties Trust (NYSE: MPW) has been struggling because of tenant issues, which has made it more difficult for the real estate investment trust (REIT) to manage its large debt load. The

Why Arm Holdings Stock Is Jumping Today: https://g.foolcdn.com/editorial/images/784306/gettyimages-2148797906.jpg
Why Arm Holdings Stock Is Jumping Today

Arm Holdings (NASDAQ: ARM) stock is advancing in Tuesday's trading. The semiconductor company's share price was up 5% as of 3 p.m. ET, according to data from S&P Global Market Intelligence.

While

Agilent to Acquire North American CDMO BIOVECTRA: https://mms.businesswire.com/media/20240722078870/en/2191539/5/1_Aviation_manufacturing_mod.jpg
Agilent to Acquire North American CDMO BIOVECTRA


Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization, for $925

ExxonMobil Is a Rock-Solid Dividend Stock, but So Is This Dirt Cheap Value Stock That Paid $1.8 Billion in Dividends Over the Past Year: https://g.foolcdn.com/editorial/images/783635/gettyimages-149319933-1200x800-5b2df79-2.jpg
ExxonMobil Is a Rock-Solid Dividend Stock, but So Is This Dirt Cheap Value Stock That Paid $1.8 Billion in Dividends Over the Past Year

In addition to being the most valuable U.S.-based energy company, ExxonMobil is a consistent dividend payer, with over 42 consecutive years of raising its payout. With a diversified business model

UnitedHealth Group Rallies Despite Continued Cyberattack Cost Pressures. Is It Too Late to Buy the Stock?: https://g.foolcdn.com/editorial/images/783589/gettyimages-1464901800.jpg
UnitedHealth Group Rallies Despite Continued Cyberattack Cost Pressures. Is It Too Late to Buy the Stock?

Shares of UnitedHealth Group (NYSE: UNH) were rallying despite a past cyberattack on the company's Change Healthcare business continuing to affect the company's results. But with investors now

EQS-News: Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive: https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-News: Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive
EQS-News: Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive
EQS-Adhoc: Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024: https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-Adhoc: Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024
EQS-Adhoc: Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024
Why UnitedHealth Stock Rocketed Nearly 7% Higher Today: https://g.foolcdn.com/editorial/images/783608/patient-and-physician-smiling-during-a-visit.jpg
Why UnitedHealth Stock Rocketed Nearly 7% Higher Today

A convincing bottom-line beat helped increase the share price of big health insurer UnitedHealth Group (NYSE: UNH) on Tuesday. Investors liked what they saw with the company's second-quarter